idecabtagene vicleucel (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Multiple Myeloma

Pending FDA approval for multiple myeloma

Next:

Pharmacology

Mechanism of Action

B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.